Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities

Experimental Hematology

Volumn 27, Issue 7, 1999, Pages 1113-1123

  Broxmeyer, Hal E ^a   Kim, Chang H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine receptors; Chemokines; Chemotaxis; Hematopoiesis; Stem progenitor cells

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

BLOOD CELL; CELL METABOLISM; CHEMOTAXIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MYELOPOIESIS; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 0033020968     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00045-4     Document Type: Article

References (147)

1. Kim C.H., Broxmeyer H.E. Chemokines. signal lamps for trafficking of T- and B-cells for development and effector function (review) J Leukoc Biol. 65:1999;6.
2. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565.
3. Rollins B.J. Chemokines. Blood. 90:1997;909.
4. Baggiolini M., Dewald B., Moser B. Human chemokines. an update Annu Rev Immunol. 15:1997;675.
5. Murphy P.M. Chemokine receptors. structure, function and role in microbial pathogenesis Cytokine Growth Factor Rev. 7:1996;47.
6. Graham G.J., Wright E.G., Hewick R., Wolpe S.D., Wilkie N.M., Donaldson D., Lorimore S., Pragnell I.B. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 344:1990;442.
7. Broxmeyer H.E., Sherry B., Lu L., Cooper S., Oh K.-O., Tekamp-Olson P., Kwon B.S., Cerami A. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 76:1990;1110.
8. 3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1 induced chemotaxis of progenitors. Ann N Y Acad Sci 872:142.
9. Broxmeyer H.E., Sherry B., Lu L., Cooper S., Carow C., Wolpe S.D., Cerami A. Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 in vitro on colony formation by murine and human bone marrow granulocyte-macrophage progenitor cells. J Exp Med. 170:1989;1583.
10. Broxmeyer H.E., Sherry B., Cooper S., Ruscetti F.W., Williams D.E., Arosio P., Kwon B.S., Cerami A. Macrophage inflammatory protein (MIP)-1β abrogates the capacity of MIP-1α to suppress myeloid progenitor cell growth. J Immunol. 147:1991;2586.
11. Broxmeyer H.E., Sherry B., Cooper S., Lu L., Maze R., Beckmann M.P., Cerami A., Ralph P. Comparative analysis of the suppressive effects of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. J Immunol. 150:1993;3448.
12. Mantel C., Kim Y.-J., Cooper S., Kwon B., Broxmeyer H.E. Polymerization of murine macrophage inflammatory protein-1α inactivates its myelosuppressive effects in vitro. The active form is monomer. Proc Natl Acad Sci U S A. 90:1993;2232.
13. Broxmeyer Cooper S., Hague N., Benninger L., Sarris A., Cornetta K., Vadhan-Raj S., Hendrie P., Mantel C. Human chemokines. enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor dependent cell line and in vivo in mice Ann Hematol. 71:1995;235.
14. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol. 21:1993;1442.
15. Clements J.M., Craig S., Gearing A.J.H., Hunter M.G., Heyworth C.M., Dexter T.M., Lord B.I. Biological and structural properties of MIP-1α expressed in yeast. Cytokine. 4:1992;76.
16. Graham G.J., Freshney M.G., Donaldson D., Pragnell I.B. Purification and biochemical characterization of human and murine stem cell inhibitors (SCI). Growth Factors. 7:1992;151.
17. Keller J.R., Bartelmez S.H., Sitnicka E., Ruscetti F.W., Ortiz M., Gooya J.M., Jacobsen S.E.W. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor β on hematopoietic progenitor/stem cell growth. Blood. 84:1994;2175.
18. + cells purified from cord blood and fetal liver. Exp Hematol. 23:1995;422.
19. Maze R., Sherry B., Kwon B.S., Cerami A., Broxmeyer H.E. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J Immunol. 149:1992;1004.
20. Cooper S., Mantel C., Broxmeyer H.E. Myelosuppressive effects in vivo with very low dosage of monomeric recombinant murine macrophage inflammatory protein-1α Exp Hematol. 22:1994;186.
21. Dunlop D.J., Wright E.G., Lorimore S., Graham G.J., Tolyoake T., Kerr D.J., Wolpe S.D., Pragnell I.B. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP-1α in vivo. Blood. 79:1992;2221.
22. Lord B.I., Dexter T.M., Clements J.M., Hunter M.A., Gearing A.J.H. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood. 79:1992;2605.
23. Hunter M.G., Lawden L., Brotherton D., Craig S., Cribbes S., Czaplewski L.G., Dexter T.M., Drummond A.H., Gearing A.H., Heyworth C.M., Lord B.I., McCourt M.et al. BB-10010. an active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties Blood. 86:1995;4400.
24. Bernstein S.H., Eaves C.J., Herzig R., Fay J., Lynch J., Phillips G., Christiansen N., Reece D., Ericson S., Stephan M., Kovalsy M., Hawkins K.et al. A Randomized phase II study of BB-10010. a variant of human macrophage inflammatory protein-1α for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer Brit J Haematol. 99:1997;888.
25. Broxmeyer H.E., Orazi A., Hague N.L., Sledge G.W. Jr., Rasmussen H., Gordon M.S. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cells Molecules Dis. 24:1998;14.
26. Marshall E., Howell A.H., Powles R., Miller A., Hunter M.G., Edwards M., Wood L.M., Czaplewski L., Puttick R., Warrington S., Boyce M., Testa N., Dexter T.M., Lord B.I., Millar A. Clinical effects of human macrophage inflammatory protein-1α MIP-1α (LD78) administration to humans. a phase I study in cancer patients and normal healthy volunteers with the genetically engineered varient, BB-10010 Eur J Cancer. 34:1998;1023.
27. Clemmons M.J., Marshall E., Durig J., Watanabe K., Howell A., Miles D., Earl H., Kiernan J., Griffiths A., Towlson K., DeTakats P., Testa N.G.et al. A randomized phase II study of BB-10010 (macrophage inflammary protein-1α ) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy. Blood. 92:1998;1532.
28. Haneline L., Broxmeyer H.E., Cooper S., Hangoc G., Carreau M., Buchwald M., Clapp D.W. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac -/- mice. Blood. 91:1998;4092.
29. Hromas R., Gray P.W., Chantry D., Krathwohl M., Fife K., Bell G.I., Takeda J., Aronica S., Gordon M., Cooper S., Broxmeyer H.E., Klemsz M. Cloning and characterization of exodus, a novel β-chemokine. Blood. 89:1997;3315.
30. Hromas R., Kim C.H., Klemsz M., Krathwohl M., Fife K., Cooper S., Schnizlein-Bick C., Broxmeyer H.E. Isolation and characterization of exodus-2, a novel c-c chemokine with a unique 37 amino acid carboxy terminal extension (cutting edge). J Immunol. 159:1997;2554.
31. Sarris A.H., Broxmeyer H.E., Wirthmueller U., Karasavvas N., Krueger K., Ravetch J.V. Human interferon inducible protein 10. expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors J Exp Med. 178:1993;1127.
32. Youn B.S., Jang I.-K., Broxmeyer H.E., Cooper S., Jenkins N.A., Gilbert D.J., Copeland N.G., Elick T.A., Fraser M.J. Jr., Kwon B.S. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. J Immunol. 155:1995;2661.
33. Youn B.S., Zhang S.M., Lee E.K., Park D.H., Broxmeyer H.E., Murphy P.M., Locati M., Pease J.E., Kim K.K., Antol K., Kwon B.S. Molecular cloning of leukotactin-1. a novel human β-chemokine, a chemoattractant for neutrophils, monocytes and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3 (cutting edge) J Immunol. 159:1997;5201.
34. Youn B.S., Zhang S.M., Broxmeyer H.E., Cooper S., Antol K., Fraser M., Kwon B.S. Characterization of CKβ8 and CKβ8-1. two alternatively spliced forms of human β-chemokine, chemoattractants for neutrophils, monocytes and lymphocytes, and potent agonists at CC chemokine receptor 1 Blood. 91:1998;3118.
35. Youn B.S., Zhang S., Broxmeyer H.E., Antol K., Fraser M.J. Jr., Hangoc G., Kwon B.S. Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine with myelosuppressive activity. Biochem Biophys Res Commun. 247:1998;217.
36. Gewirtz A.M., Calabretta B., Rucinski B., Niewiarowski S., Xu W.Y. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest. 83:1988;1477.
37. Gewirtz A.M., Zhang J., Ratajczak J., Ratajczak M., Park K.S., Li C., Yan Z., Poncz M. Chemokine regulation of human megakaryocytopoiesis. Blood. 86:1995;2559.
38. Han Z.C., Sensebe L., Abgrall J.F., Briere J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood. 75:1990;1234.
39. Patel V.P., Kreider B.L., Li Y., Li H., Leung K., Salcedo T., Nardelli B., Pippalla V., Gentz S., Thotakura R., Parmelee D., Gentz R.et al. Molecular and functional characterization of two novel human CC chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med. 185:1997;1163.
40. Sanchez X., Suetomi K., Cousins-Hodges B., Horton J.K., Navarro J. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2. J Immunol. 160:1998;906.
41. + human bone marrow cells. J Immunol. 159:1997;895.
42. Broxmeyer H.E., Pelus L.M., Hromas R., Kwon B., Youn B., Fife K., Krathwohl M.D., Kim C., White J.R., Hangoc G., Cooper S. Myelosuppression in vitro and in vivo by newly identified members of the cysteine cysteine (CC), CXC and C chemokine family and synergistic suppression in vivo by combinations of these chemokines (abstr). Blood. 90(suppl 1, pt 1):1997;475a.
43. Broxmeyer H.E., Cooper S., Li Z.H., Lu L., Sarris A., Wang M.H., Metz C., Chang M.S., Donner D.B., Leonard E.J. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann Hematol. 73:1996;1.
44. Broxmeyer H.E., Cooper S., Maione T., Gordon M., Daly T. Myeloprotective effects of the chemokines interleukin-8 and platelet factor 4 in a mouse model of cytosine arabinoside (ARA-C) chemotherapy (abstr). Exp Hematol. 23:1995;900.
45. Han Z.C., Lu M., Li J., Defard M., Boval B., Schlegel N., Caen J.P. Platelet-factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood. 89:1997;2328.
46. - cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1α maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood. 91:1998;4516.
47. - cells reselected from macrophage inflammatory protein 1 alpha + interleukin-3 supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells. Blood. 84:1994;1442.
48. Quackenbush E.J., Wershil B.K., Aguirre V., Gutierrez-Ramos J.C. Eotaxin modulates myelopoiesis and mast cell development from embroynic hematopoietic progenitors. Blood. 92:1998;1887.
49. Peled A., Gonzalo J.A., Lloyd C., Gutierrez-Ramos J.C. The chemotactic cytokine, eoxtaxin, acts as a granulocyte and macrophage colony stimulating factor during lung inflammation. Blood. 91:1997;1.
50. Soto H., Wang W., Strieter R.W., Copeland N.G., Gilbert D.J., Jenkins N.A., Hedrick J., Zlotnik A. The cc chemokine 6ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci U S A. 95:1998;8205.
51. Gao J.L., Wynn T.A., Chang Y., Lee E., Broxmeyer H.E., Cooper E., Tiffany H.L., Westphal H., Kwon-Chung J., Murphy P.M. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1/type 2 cytokine balance in mice lacking cc chemokine receptor 1. J Exp Med. 185:1997;1959.
52. Broxmeyer H.E., Cooper S., Hangoc G., Gao J.L., Murphy P.M. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med. in press:1999.
53. Lord B.I., Woolfard L.B., Wood L.M., Czaplewski L.G., McCourt M., Hunter M.G., Edwards R.M. Mobilization of early hematopoietic progenitor cells with BB10010. a genetically engineered variant of human macrophage inflammatory protein-1α Blood. 85:1995;3412.
54. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V. Jr., Brox meyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552.
55. Reid S., Ritchie A., Boring L., Cooper S., Hangoc G., Charo I.F., Broxmeyer H.E. Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood. 93:1999;1524.
56. Broxmeyer H.E., Cooper S., Cacalano G., Hague N.L., Bailish E., Moore M.W. Interleukin-8 receptor is involved in negative regulation of myeloid progenitor cells in vivo. Evidence from mice lacking the murine IL-8 receptor homolog J Exp Med. 184:1996;1825.
57. Ward S.G., Bacon K., Westwick J. Chemokines and T-lymphocytes. more than an attraction Immunity. 9:1998;1.
58. Mantel C., Aronica S., Luo Z., Marshall M.S., Kim Y.-J., Broxmeyer H.E. Macrophage inflammatory protein 1α enhances growth-factor stimulated phospholipid turnover and increases cAMP levels in the human factor-dependent cell line, M07e. J Immunol. 154:1995;2342.
59. Cashman J.D., Eaves C.J., Sarris A.H., Eaves A.C. MCP-1, not MIP-1α, is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in Long-term human marrow cultures. Blood. 92:1998;2338.
60. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391:1998;799.
61. Legler D.F., Loetscher M., Roos R.S., Clark Lewis I., Baggiolini M., Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 187:1998;655.
62. Orlofsky A., Lin E.Y., Prystowsky M.B. Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages. J Immunol. 152:1994;5084.
63. Orlofsky A., Berger M.S., Prystowsky M.B. Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul. 2:1991;403.
64. Rossi D.L., Vicari A.P., Franz-Bacon K., McClanahan T.K., Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines. MIP-3alpha and MIP-3beta J Immunol. 158:1997;1033.
65. Yoshida R., Imai T., Hieshima K., Kusuda J., Baba M., Kitaura M., Ni-shimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem. 272:1997;13803.
66. Ngo V.N., LucyTang H., Cyster J.G. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med. 188:1998;181.
67. Kim C.H., Pelus L.M., White J.R., Broxmeyer H.E. MIP-3 beta/ELC/CKβ-11 is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells. J Immunol. 161:1998;2580.
68. Adema G.J., Hartgers F., Verstraten R., de Vries E., Marland G., Menon S., Foster J., Xu Y., Nooyen P., McClanahan T., Bacon K.B., Figdor C.G. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 387:1997;713.
69. Hieshima K., Imai T., Baba M., Shoudai K., Ishizuka K., Nakagawa T., Tsuruta J., Takeya M., Sakaki Y., Takatsuki K., Miura R., Opdenakker G.et al. A novel human CC chemokine PARC that is most homologous to macrophage- inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol. 159:1997;1140.
70. Z'Graggen K., Walz A., Mazzucchelli L., Strieter R.M., Mueller C. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology. 113:1997;808.
71. Lukacs N.W., Hogaboam C.M., Kunkel S.L., Chensue S.W., Burdick M.D., Evanoff H.L., Strieter R.M. Mast cells produce ENA-78, which can function as a potent neutrophil chemoattractant during allergic airway inflammation. J Leukoc Biol. 63:1998;746.
72. Walz A., Schmutz P., Mueller C., Schnyder-Candrian S. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol. 62:1997;604.
73. Keates S., Keates A.C., Mizoguchi E., Bhan A., Kelly C.P. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol. 273:1997;G75.
74. Rovai L.E., Herschman H.R., Smith J.B. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue- specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol. 64:1998;494.
75. Jose P.J., Adcock I.M., Griffiths-Johnson D.A., Berkman N., Wells T.N., Williams T.J., Power C.A. Eotaxin. cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs Biochem Biophys Res Commun. 205:1994;788.
76. Rothenberg M.E., Luster A.D., Lilly C.M., Drazen J.M., Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med. 181:1995;1211.
77. Rothenberg M.E., Luster A.D., Leder P. Murine eotaxin. an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression Proc Natl Acad Sci U S A. 92:1995;8960.
78. Ganzalo J.A., Jia G.Q., Aguirre V., Friend D., Coyle A.J., Jenkins N.A., Lin G.S., Katz H., Lichtman A., Copeland N., Kopf M., Gutierrez-Ramos J.C. Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 4:1996;1.
79. Kitaura M., Nakajima T., Imai T., Harada S., Combadiere C., Tiffany H.L., Murphy P.M., Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 271:1996;7725.
80. Bartels J., Schluter C., Richter E., Noso N., Kulke R., Christophers E., Schroder J.M. Human dermal fibroblasts express eotaxin. molecular cloning, mRNA expression, and identification of eotaxin sequence variants Biochem Biophys Res Commun. 225:1996;1045.
81. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:1997;640.
82. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G.et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation [published erratum appears in Nature 1997;389(6646):100]. Nature. 387:1997;611.
83. Van Damme J., Wuyts A., Froyen G., Van Coillie E., Struyf S., Billiau A., Proost P., Wang J.M., Opdenakker G. Granulocyte chemotactic protein-2 and related CXC chemokines. from gene regulation to receptor usage J Leukoc Biol. 62:1997;563.
84. Teixeira M.G., Austin K.J., Perry D.J., Dooley V.D., Johnson G.A., Francis B.R., Hansen T.R. Bovine granulocyte chemotactic protein-2 is secreted by the endometrium in response to interferon-tau (IFN-tau). Endocrine. 6:1997;31.
85. Wuyts A., Haelens A., Proost P., Lenaerts J.P., Conings R., Opdenakker G., Van Damme J. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J Immunol. 157:1996;1736.
86. Haskill S., Peace A., Morris J., Sporn S.A., Anisowicz A., Lee S.W., Smith T., Martin G., Ralph P., Sager R. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A. 87:1990;7732.
87. Sager R., Haskill S., Anisowicz A., Trask D., Pike M.C. GRO. a novel chemotactic cytokine Adv Exp Med Biol. 305:1991;73.
88. Cuenca R.E., Azizkhan R.G., Haskill S. Characterization of GRO alpha, beta and gamma expression in human colonic tumours. potential significance of cytokine involvement [published erratum appears in Surg Oncol 1992;1(6):417] Surg Oncol. 1:1992;323.
89. Becker S., Quay J., Koren H.S., Haskill J.S. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am J Physiol. 266:1994;L278.
90. Luan J., Shattuck-Brandt R., Haghnegahdar H., Owen J.D., Strieter R., Burdick M., Nirodi C., Beauchamp D., Johnson K.N., Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol. 62:1997;588.
91. Schulz-Knappe P., Mägert H.J., Dewald B., Meyer M., Cetin Y., Kubbies M., Tomeczkowski J., Kirchhoff K., Raida M., Adermann K. HCC-1, a novel chemokine from human plasma. J Exp Med. 183:1996;295.
92. Pardigol A., Forssmann U., Zucht H.D., Loetscher P., Schulz-Knappe P., Baggiolini M., Forssmann W.G., Magert H.J. HCC-2, a human chemokine. gene structure, expression pattern, and biological activity Proc Natl Acad Sci U S A. 95:1998;6308.
93. Hedrick J.A., Helms A., Vicari A., Zlotnik A. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood. 91:1998;4242.
94. Shoudai K., Hieshima K., Fukuda S., Iio M., Miura R., Imai T., Yoshie O., Nomiyama H. Isolation of cDNA encoding a novel human CC chemokine NCC-4/LEC. Biochim Biophys Acta. 1396:1998;273.
95. Selvan R.S., Zhou L.J., Krangel M.S. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol. 27:1997;687.
96. Imai T., Yoshida T., Baba M., Nishimura M., Kakizaki M., Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem. 271:1996;21514.
97. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:1994;97.
98. Luster A.D., Unkeless J.C., Ravetch J.V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 315:1985;672.
99. Farber J.M. Mig and IP-10. CXC chemokines that target lymphocytes J Leukoc Biol. 61:1997;246.
100. Neville L.F., Abdullah F., McDonnell P.M., Young P.R., Feuerstein G.Z., Rabinovici R. Mob-1 expression in IL-2-induced ARDS. regulation by TNF-alpha Am J Physiol. 269:1995;L884.
101. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., Sahagan B.G., Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC). a novel non- ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 J Exp Med. 187:1998;2009.
102. Yoshida T., Imai T., Kakizaki M., Nishimura M., Yoshie O. Molecular cloning of a novel C or gamma type chemokine, SCM-1. FEBS Lett. 360:1995;155.
103. Kelner G.S., Kennedy J., Bacon K.B., Kleyensteuber S., Largaespada D.A., Jenkins N.A., Copeland N.G., Bazan J.F., Moore K.W., Schall T.J., Zlotnick A. Lymphotactin. a cytokine that represents a new class of chemokine Science. 266:1994;1395.
104. Kennedy J., Kelner G.S., Kleyensteuber S., Schall T.J., Weiss M.C., Yssel H., Schneider P.V., Cocks B.G., Bacon K.B., Zlotnik A. Molecular cloning and functional characterization of human lymphotactin. J Immunol. 155:1995;203.
105. + T lymphocytes. Eur J Immunol. 25:1995;1744.
106. Van Damme J., Proost P., Lenaerts J.P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med. 176:1992;59.
107. Chang H.C., Hsu F., Freeman G.J., Griffin J.D., Reinherz E.L. Cloning and expression of a gamma-interferon-inducible gene in monocytes. a new member of a cytokine gene family Int Immunol. 1:1989;388.
108. Minty A., Chalon P., Guillemot J.C., Kaghad M., Liauzun P., Magazin M., Miloux B., Minty C., Ramond P., Vita N. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur Cytokine Network. 4:1993;99.
109. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., La-vigne F., Hamid Q., Murphy P.M., Luster A.D. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol. 157:1996;5613.
110. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5. a novel CC chemokine that is a structural and functional homologue of human MCP-1 J Exp Med. 185:1997;99.
111. Chang M., McNinch J., Elias C 3rd, Manthey C.L., Grosshans D., Meng T., Boone T., Andrew D.P. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J Biol Chem. 272:1997;25229.
112. Godiska R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., Mantovani A., Gray P.W. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 185:1997;1595.
113. Schaniel C., Pardali E., Sallusto F., Speletas M., Ruedl C., Shimizu T., Seidl T., Anderson J., Melchers F., Rolink A.G., Sideras P. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med. 188:1998;451.
114. Farber J.M. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci U S A. 87:1990;5238.
115. Obaru K., Fukuda M., Maeda S., Shimada K. A cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumor promoter. J Biochem (Tokyo). 99:1986;885.
116. Nakao M., Nomiyama H., Shimada K. Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol. 10:1990;3646.
117. Lipes M.A., Napolitano M., Jeang K.T., Chang N.T., Leonard W.J. Identification, cloning, and characterization of an immune activation gene. Proc Natl Acad Sci U S A. 85:1988;9704.
118. Recklies A.D., Golds E.E. Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum. 35:1992;1510.
119. Forssmann U., Delgado M.B., Uguccioni M., Loetscher P., Garotta G., Baggiolini M. CKbeta8, a novel CC chemokine that predominantly acts on monocytes. FEBS Lett. 408:1997;211.
120. Skerka C., Irving S.G., Bialonski A., Zipfel P.F. Cell type specific expression of members of the IL-8/NAP-1 gene family. Cytokine. 5:1993;112.
121. Zhang C., Gadue P., Scott E., Atchison M., Poncz M. Activation of the megakaryocyte-specific gene platelet basic protein (PBP) by the Ets family factor PU.1. J Biol Chem. 272:1997;26236.
122. Deuel T.F., Senior R.M., Chang D., Griffin G.L., Heinrikson R.L., Kaiser E.T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A. 78:1981;4584.
123. Miller M.D., Hata S., De Waal Malefyt R., Krangel M.S. A novel polypeptide secreted by activated human T lymphocytes. J Immunol. 143:1989;2907.
124. Kameyoshi Y., Dorschner A., Mallet A.I., Christophers E., Schroder J.M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med. 176:1992;587.
125. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap. a cloning strategy for secreted proteins and type I membrane proteins Science. 261:1993;600.
126. Shirozu M., Nakao T., Inazawa J., Tashiro K., Tada H., Shinohara T., Honjo T. Structure and chromosomal location of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 28:1995;495.
127. Bleul C.C., Schultze J.L., Springer T.A. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med. 187:1998;753.
128. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A. 95:1998;258.
129. Nagira M., Imai T., Hieshima K., Kusuda J., Ridanpää M., Takagi S., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem. 272:1997;19518.
130. Yoshie O., Imai T., Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol. 62:1997;634.
131. Vicari A.P., Figueroa D.J., Hedrick J.A., Foster J.S., Singh K.P., Menon S., Copeland N.G., Gilbert D.J., Jenkins N.A., Bacon K.B., Zlotnik TECK. a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development Immunity. 7:1997;291.
132. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking CXC chemokine PBSF/SDF-1. Nature. 382:1996;635.
133. Zou Y.-R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:1998;595.
134. + progenitors to peripheral blood. J Exp Med. 185:1997;111.
135. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants. stromal cell-derived factor-1, steel factor and the bone marrow environment Blood. 91:1998;100.
136. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 91:1998;4523.
137. Wang J.-F., Liu Z.-Y., Groopman J.E. The α-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood. 92:1998;756.
138. FAK) and paxillin. Blood. 89:1997;1574.
139. Gotoh A., Takahira H., Geahlen R.L., Broxmeyer H.E. Cross-linking of integrins induces tyrosine phosphorylation of proto-oncogene product vav and protein tyrosine kinase Syk in a human factor-dependent myeloid cell line. Cell Growth Differ. 8:1997;721.
140. Gotoh A., Ritchie A., Takahira H., Broxmeyer H.E. Thrombopoietin and erythropoietin acivate inside-out signal of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells. Ann Hematol. 75:1997;207.
141. Shibayama H., Anzai N., Braun S.E., Fukuda S., Mantel C., Broxmeyer H.E. H-Ras is involved in the inside-out signaling pathway of IL-3 induced integrin activation. Blood. 93:1999;1540.
142. Gotoh A., Reid S., Miyazawa K., Broxmeyer H.E. SDF-1 suppresses cytokine-induced adhesion of human hematopoietic progenitor cells to immobilized fibronectin. Brit J Haematol. in press:1999.
143. Kim C.H., Broxmeyer H.E. CCR7 and CXCR3 ligand SLC/Exodus 2/6CKine/TCA4 induces chemotaxis of hematopoietic progenitor cells. Differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis/actin polymerization vs. suppression of progenitor proliferation J Leuk Biol. in press:1999.
144. Kim C.H., Pelus L.M., White J.R., Broxmeyer H.E. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood. 91:1998;4434.
145. Kim C.H., Pelus L.M., White J.R., Appelbaum E., Johanson K., Broxmeyer H.E. CKβ-11/MIP-3β/EB-I1-ligand chemokine (ELC) is an efficacious chemoattractant for T- and B-cells. J Immunol. 160:1998;2418.
146. Laterveer L., Lindley J.D., Hamilton M.S., Willemze R., Fibbe W.F. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood. 85:1995;2269.
147. Daly T.J., LaRosa G.J., Dolich S., Maione T.E., Cooper S., Broxmeyer H.E. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4. J Biol Chem. 270:1995;23282.